J&J Talc Deal Should Be Rejected in Bankruptcy, Holdouts Say

Jan. 27, 2025, 7:04 PM UTC

Holdout creditors who claim tainted baby powder gave them ovarian cancer urged a judge to reject Johnson & Johnson’s plan to force an end to all related cancer lawsuits.

The proposed settlement — worth more than $8 billion — wrongly denies ovarian cancer victims the right to pursue their claims in court, lawyers for women who refused to join the deal said in a Friday objection. Holdouts also challenged a claim from J&J and its supporters that the settlement is backed by more than 80% of claimants.

Under the proposal, a bankrupt unit of the health care giant would ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.